Anxiety News and Research RSS Feed - Anxiety News and Research

Anxiety disorder is a mental ailment that leads to unnecessary anxiety over different activities and events.
Antidepressant treatment results in lower rate of MSIMI

Antidepressant treatment results in lower rate of MSIMI

Among patients with stable coronary heart disease and mental stress-induced myocardial ischemia (MSIMI), 6 weeks of treatment with the antidepressant escitalopram, compared with placebo, resulted in a lower rate of MSIMI, according to a study in the May 22/29 issue of JAMA. [More]

Mayo Clinic expert offers tips for children with weather-related fears

Violent storms — often accompanied by lightning, thunder, heavy rain, powerful winds and even tornado warnings — can be stressful for anyone, but severe weather can trigger much more severe anxiety, especially among children. [More]
New research suggests that listening to music lowers anxiety, sedation in ventilated patients

New research suggests that listening to music lowers anxiety, sedation in ventilated patients

New research suggests that for some hospitalized ICU patients on mechanical ventilators, using headphones to listen to their favorite types of music could lower anxiety and reduce their need for sedative medications. [More]
Stronger epigenetic changes in estrogen responsive genes linked to postpartum depression

Stronger epigenetic changes in estrogen responsive genes linked to postpartum depression

The epigenetic modifications, which alter the way genes function without changing the underlying DNA sequence, can apparently be detected in the blood of pregnant women during any trimester, potentially providing a simple way to foretell depression in the weeks after giving birth, and an opportunity to intervene before symptoms become debilitating. [More]
UTMB researchers awarded grant to study gene therapy techniques to eliminate neuropathic pain

UTMB researchers awarded grant to study gene therapy techniques to eliminate neuropathic pain

University of Texas Medical Branch at Galveston researchers have been awarded a five-year, $1.8 million grant by the National Institute of Neurological Disorders and Stroke to apply the techniques of gene therapy to the problem of neuropathic pain - that is, pain that arises from a malfunction in the nervous system. [More]
Takeda, Lundbeck announce presentation of data from four studies that evaluate vortioxetine for MDD

Takeda, Lundbeck announce presentation of data from four studies that evaluate vortioxetine for MDD

Takeda Pharmaceutical Company Limited and H. Lundbeck A/S today announced that the companies will be presenting new data from four studies that evaluated effectiveness in treating the overall symptoms of depression in patients taking vortioxetine, an investigational agent under review with the U.S. Food and Drug Administration for the treatment of major depressive disorder. [More]
Researchers link coffee consumption with reduced risk of primary sclerosing cholangitis

Researchers link coffee consumption with reduced risk of primary sclerosing cholangitis

Research presented today at Digestive Disease Week explores new discoveries in liver disease research, with findings about the impact of coffee on autoimmune disease and palliative care for cirrhotic patients. [More]
Students receive Addiction Science Award at 2013 Intel International Science and Engineering Fair

Students receive Addiction Science Award at 2013 Intel International Science and Engineering Fair

An exploration of electronic "screen time" and sleep on mood, memory and learning was given the top Addiction Science Award at the 2013 Intel International Science and Engineering Fair - the world's largest science competition for high school students. [More]
Shire's scientific data on treatments for psychiatric disorders to be presented at APA meeting

Shire's scientific data on treatments for psychiatric disorders to be presented at APA meeting

Shire plc, the global specialty biopharmaceutical company, announces that it will present scientific data in 7 poster presentations at the American Psychiatric Association 166th Annual Meeting in San Francisco, May 18-22. [More]
Spontaneous brain activity in amygdala higher among combat veterans with PTSD

Spontaneous brain activity in amygdala higher among combat veterans with PTSD

Chronic trauma can inflict lasting damage to brain regions associated with fear and anxiety. Previous imaging studies of people with post-traumatic stress disorder, or PTSD, have shown that these brain regions can over-or under-react in response to stressful tasks, such as recalling a traumatic event or reacting to a photo of a threatening face. [More]
UC Davis scientists detect novel molecular target for multiple sclerosis

UC Davis scientists detect novel molecular target for multiple sclerosis

Working with lab mice models of multiple sclerosis, UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved medications against MS. [More]
Weekend reading: Volunteers in the battle with heart disease; Psychiatry without medication; Owning your genes

Weekend reading: Volunteers in the battle with heart disease; Psychiatry without medication; Owning your genes

Psychiatrists who take time with their patients are not the norm. It's not because others don't care. Rather the system rewards efficiency, not empathy. [More]

Roundup: N.D. abortion clinic sues to stop new law; Health care savings close budget hole in Conn.; Calif. counties struggle to expand mental health care

The running battle over the regulation of abortions entered a North Dakota courtroom on Wednesday, as the state's sole abortion clinic sued to block a new law that it says could force it to shut down. The law, requiring doctors performing abortions to have admitting privileges at a nearby hospital, was promoted by anti-abortion legislators, who argued that it would mean better care for women who suffer medical emergencies (Eckholm, 5/15). [More]
Imaging scans do little help to detect relapse of diffuse large B-cell lymphoma

Imaging scans do little help to detect relapse of diffuse large B-cell lymphoma

Imaging scans following treatment for diffuse large B-cell lymphoma do little to help detect a relapse, a Mayo Clinic study has found. [More]

New GWA can pose major ethical problems if used incorrectly, say ESHG recommendations

The use of genome-wide analysis, where the entirety of an individual's DNA is examined to look for the genomic mutations or variants which can cause health problems is a massively useful technology for diagnosing disease. [More]

Doctors transform how they practice medicine

Kaiser Health News staff writer Ankita Rao reports: "The buzz, and anxiety, in the medical profession is palpable – trade magazines tout new coping strategies, doctor groups discuss the transformation of practices. Physicians are experimenting with business models and new practice techniques, hoping to find work that is both financially and personally rewarding" (Rao, 5/15). [More]
Depression and time perception: an interview with Dr Rachel Msetfi, University of Limerick

Depression and time perception: an interview with Dr Rachel Msetfi, University of Limerick

In clinical terms, depression is defined by the presence of a cluster of symptoms. The Diagnostic Manual used by many psychologists and psychiatrists cites nine symptoms of depression, of which five must be present for a two-week period. [More]

Are the health law's coverage requirements scaling back some restaurants' expansion plans?

Some restaurant operators are scaling back expansion plans because of uncertainty about the expense of insuring employees under the new federal health-care law. [More]

First Edition: May 15, 2013

Today's headlines include reports about how the latest Congressional Budget Office projections could further stall efforts to reach a grand bargain that includes changes to Medicare and other entitlement programs. [More]

CATs improve anxiety, depression, pain symptoms and quality of life among cancer patients

Creative arts therapies can improve anxiety, depression, pain symptoms and quality of life among cancer patients, although the effect was reduced during follow-up in a study by Timothy W. Puetz, Ph.D., M.P.H., of the National Institutes of Health, Bethesda, Md., and colleagues. [More]